Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China: Duloxetine Versus Placebo.
Phase of Trial: Phase III
Latest Information Update: 04 May 2015
At a glance
- Drugs Duloxetine (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Jun 2013 Planned End Date changed from 1 Sep 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.